Skip to content

Effect of melatonin in septic patients

Investigating Cardio protective effects of melatonin in preventing of sepsis associated cardiomyopathy in ICU admitted septic patients

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240713062425N1
Enrollment
34
Registered
2025-02-03
Start date
2025-02-08
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

SEPSIS. Severe sepsis with septic shock

Interventions

Intervention group: 10 mg melatonin tablets from Norm Life company are taken every 8 hour for 7 days..

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: Patients 18 to 85 years old Based on diagnostic criteria (increase of at least 2 SOFA scores compared to baseline in patients suspected of infection), sepsis should be considered for the patient. The patient or the patient's companion must have an informed and freely written consent form to participate in the study.

Exclusion criteria

Exclusion criteria: Severe heart failure Severe liver dysfunction (liver enzyme more than three times the normal limit) Pregnancy and lactation Dialysis patients History of hypersensitivity or any contraindications to melatonin Previous history of cardiovascular attacks Uncontrolled diabetes (HbA1C>8.5)

Design outcomes

Primary

MeasureTime frame
Investigating the effects of high dose melatonin in the prevention of heart damage secondary to sepsis. Timepoint: The beginning of the study (before intervention) and 7 days after the start of melatonin consumption. Method of measurement: Laboratory kit for measuring NT-PROBNP blood samples.

Secondary

MeasureTime frame
Investigating the effects of high doses of melatonin on Troponin I levels in the prevention of heart damage secondary to sepsis. Timepoint: The beginning of the study (before intervention) and 7 days after the start of melatonin consumption. Method of measurement: Laboratory kit for measuring Troponin I blood samples.;Investigating the effects of high doses of melatonin on the duration of mechanical ventilation. Timepoint: The beginning of the study (before intervention) and 7 days after the start of melatonin consumption. Method of measurement: Clinical observation.;Investigating the effects of high doses of melatonin on the duration of hospitalization in the intensive care unit. Timepoint: The beginning of the study (before the start of the intervention) until the time of discharge from the ICU. Method of measurement: Clinical observation.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahdi Emami

Tehran University of Medical Sciences

Mahdi.emami31@yahoo.com+98 21 6634 8500

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026